Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Lignin in Treatment of Helicobacter Pylori Infection [Phase 3]
A Phase 3 clinical trial is evaluating lignin for treating Helicobacter pylori infection; the study is currently active but not recruiting.
-
FDA approval · 2025-11-21FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the combination therapy Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochlori…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication [Phase 2, Phase 3]
A head-to-head Phase 2/3 clinical trial comparing tegoprazan 50 mg twice daily plus amoxicillin 1 g three times daily with vonoprazan 20 mg …
-
FDA approval · 2025-11-06FDA Approved: VOQUEZNA — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna (vonoprazan fumarate) from Phathom Pharmaceuticals, expanding its labeling for Heli…
-
FDA approval · 2025-10-31FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan and amoxicillin from Phathom Pharmaceuticals,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-10-31FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)
The FDA approved a supplemental application for Voquezna Triple Pak, a three-drug regimen of vonoprazan fumarate, amoxicillin, and clarithro…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study [NA]
A population-based study in Bhutan investigates Helicobacter pylori infection and related gastric diseases in the community.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Tailored Therapy for Clarithromycin-Resistant H. Pylori [NA]
A completed clinical trial evaluating tailored therapy for clarithromycin-resistant Helicobacter pylori infection.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Efficacy of Carminal in Helicobacter Pylori Gastritis [Phase 2]
A Phase 2 clinical trial update indicates Carminal is being studied for efficacy in Helicobacter pylori–related gastritis and infection, wit…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients [Phase 4]
Phase 4 clinical trial update comparing dual Helicobacter pylori eradication therapy versus a proton pump inhibitor regimen for preventing g…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Rescue Therapy for Helicobacter Pylori Infection [Phase 4]
Phase 4 trial evaluating a rescue therapy for Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection [NA]
A clinical trial is comparing potassium-competitive acid blockers with proton pump inhibitors as part of a bismuth-based quadruple regimen f…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
The trial evaluating a bismuth-containing quadruple therapy for Helicobacter pylori infection has completed.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Huazhi Rougan Granule as an Add-On Therapy for H. Pylori Infection With Metabolic-associated Steatohepatitis [NA]
Clinical trial entry evaluating Huazhi Rougan Granule as add-on therapy for Helicobacter pylori infection with metabolic-associated steatohe…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Associating Gastric Infection With Autoimmune Flare Severity in an Egyptians
Assiut University is updating a clinical trial to evaluate whether Helicobacter pylori gastric infection influences the severity of autoimmu…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq [NA]
A completed clinical trial from Al-Mustansiriyah University evaluated Helicobacter pylori eradication therapy in patients with immune thromb…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection [Phase 4]
A Phase 4 clinical trial evaluating whether susceptibility-testing guided therapy improves outcomes compared with empirical therapy for refr…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia [Phase 4]
Phase 4 clinical trial evaluating a 14-day Modified Bismuth Quadruple Therapy for Helicobacter pylori eradication in areas with high resista…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: to Assess the Eradication Rate of 14-day Bismuth/Amoxicillin/PCAB Triple Therapy for the Treatment of Helicobacter Pylori Infection [NA]
The document reports an ongoing clinical trial evaluating a 14-day triple therapy consisting of bismuth, amoxicillin, and a potassium-compet…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication [NA]
A clinical trial is evaluating the efficacy of a vonoprazan-based rescue therapy for Helicobacter pylori eradication. The study status is No…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Efficacy and Safety of Rifasutenizol (TNP 2198), Rabeprazole and Amoxicillin in Participants With H. Pylori Infection [Phase 3]
Phase 3 trial evaluating rifasutenizol (TNP 2198) in combination with rabeprazole and amoxicillin for Helicobacter pylori infection has comp…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Screening Strategy for Gastric Cancer Prevention [NA]
A clinical trial is evaluating a screening strategy to prevent gastric cancer in individuals with Helicobacter pylori infection, and the stu…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial [Phase 4]
Phase 4 clinical trial evaluating vonoprazan combined with different antibiotics in dual therapy for Helicobacter pylori eradication, curren…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment [Phase 4]
Ongoing Phase 4 trial evaluating the efficacy and safety of a Keverprazan-amoxicillin dual therapy as first-line treatment for Helicobacter …
-
CLINICAL_TRIALS other · 2025-08-14Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Probit-Based Triple Therapy for Helicobacter Pylori Eradication [Phase 4]
An administrative update notes a Phase 4 trial evaluating probit-based triple therapy for Helicobacter pylori eradication. The study is curr…